TAT-cyclo-CLLFVY TFA

Tax included
TAT-cyclo-CLLFVY TFA is a cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells. TAT-cyclo-CLLFVY TFA disrupts HIF-1α/HIF-1β protein-protein interaction with an IC50 of 1.3 μM.
MedChemExpress 
HY-P1420A

Data sheet

Size
Multiple sizes
Reactivity
HIF/HIF Prolyl-Hydroxylase
Application
Metabolism-sugar/lipid metabolism